WO2005082336A3 - Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel - Google Patents

Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel Download PDF

Info

Publication number
WO2005082336A3
WO2005082336A3 PCT/EP2005/002033 EP2005002033W WO2005082336A3 WO 2005082336 A3 WO2005082336 A3 WO 2005082336A3 EP 2005002033 W EP2005002033 W EP 2005002033W WO 2005082336 A3 WO2005082336 A3 WO 2005082336A3
Authority
WO
WIPO (PCT)
Prior art keywords
plaster
active ingredient
kit
agent
skin irritation
Prior art date
Application number
PCT/EP2005/002033
Other languages
English (en)
French (fr)
Other versions
WO2005082336A2 (de
Inventor
Heinrich Kugelmann
Johannes Bartholomaeus
Kerdar Rasoul Sedaghat
Original Assignee
Gruenenthal Gmbh
Heinrich Kugelmann
Johannes Bartholomaeus
Kerdar Rasoul Sedaghat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh, Heinrich Kugelmann, Johannes Bartholomaeus, Kerdar Rasoul Sedaghat filed Critical Gruenenthal Gmbh
Priority to EP05707637A priority Critical patent/EP1720529A2/de
Publication of WO2005082336A2 publication Critical patent/WO2005082336A2/de
Publication of WO2005082336A3 publication Critical patent/WO2005082336A3/de
Priority to US11/509,613 priority patent/US20070053965A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Kit aus einem wirkstoffhaltigen Pflaster zur transdermalen Abgabe eines pharmazeutischen Wirkstoffs und einem davon separierten Hautirritationen wenigstens reduzierenden Mittel.
PCT/EP2005/002033 2004-02-26 2005-02-25 Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel WO2005082336A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05707637A EP1720529A2 (de) 2004-02-26 2005-02-25 Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel
US11/509,613 US20070053965A1 (en) 2005-02-25 2006-08-25 Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004009904A DE102004009904A1 (de) 2004-02-26 2004-02-26 Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
DE102004009904.9 2004-02-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/509,613 Continuation US20070053965A1 (en) 2005-02-25 2006-08-25 Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation

Publications (2)

Publication Number Publication Date
WO2005082336A2 WO2005082336A2 (de) 2005-09-09
WO2005082336A3 true WO2005082336A3 (de) 2006-05-26

Family

ID=34877203

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/002033 WO2005082336A2 (de) 2004-02-26 2005-02-25 Kit aus einem gegebenenfalls wirkstoffhaltigen pflaster und einem hautirritationen verhindernden mittel

Country Status (3)

Country Link
EP (1) EP1720529A2 (de)
DE (1) DE102004009904A1 (de)
WO (1) WO2005082336A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006001162A1 (de) * 2006-01-06 2007-07-12 Labtec Gmbh Pflasterabdeckung bei atopischer Dermatitis
DE102006019293A1 (de) * 2006-04-21 2007-10-25 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Pflaster, enthaltend ein Fentanyl Analogum

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1316308A1 (de) * 1997-12-15 2003-06-04 The Regents of the University of California Transdermale therapeutische Vorrichtung mit Capsaicin und seinen Analogen
WO2003057307A1 (en) * 2001-12-26 2003-07-17 Hill-Rom Services, Inc. Wound vacuum therapy dressing kit
WO2004021990A2 (en) * 2002-09-05 2004-03-18 Neurogesx, Inc. Compositions and kits for the removal of irritating compounds from bodily surfaces

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2782727B2 (ja) * 1988-09-08 1998-08-06 三菱瓦斯化学株式会社 フィルム状脱酸素剤
TW206152B (de) * 1991-03-20 1993-05-21 Kuko Seiyaku Kk
GR1002807B (el) * 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US6180133B1 (en) * 1997-11-25 2001-01-30 Watson Pharmaceuticals, Inc. Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
FR2781667B1 (fr) * 1998-07-30 2001-06-01 Oreal Patch cosmetique, pharmaceutique, ou dermatologique
WO2000045795A2 (en) * 1999-02-05 2000-08-10 Cipla Limited Topical sprays comprising a film forming composition
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
DE10054479A1 (de) * 2000-11-03 2002-05-08 Henkel Kgaa Kosmetische Pflaster zur Hautaufhellung
DE10121471A1 (de) * 2001-05-02 2002-11-07 Beiersdorf Ag Oberflächendotierte wirkstoffhaltige Pflaster
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1316308A1 (de) * 1997-12-15 2003-06-04 The Regents of the University of California Transdermale therapeutische Vorrichtung mit Capsaicin und seinen Analogen
WO2003057307A1 (en) * 2001-12-26 2003-07-17 Hill-Rom Services, Inc. Wound vacuum therapy dressing kit
WO2004021990A2 (en) * 2002-09-05 2004-03-18 Neurogesx, Inc. Compositions and kits for the removal of irritating compounds from bodily surfaces

Also Published As

Publication number Publication date
DE102004009904A1 (de) 2005-09-22
WO2005082336A2 (de) 2005-09-09
EP1720529A2 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
WO2006124047A3 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
WO2004021968A3 (en) Solution for ungual application
WO2007127158A3 (en) Modification of percutaneous absorption of topically active materials
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
WO2009061431A3 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2007135193A3 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
ZA200702960B (en) Fungicidal active ingredient combinations containing fluoxastrobin
WO2007025005A3 (en) Sustained release formulations of nalbuphine
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
HUP0401512A3 (en) Transdermal therapeutic system (tts) with fentanyl as active ingredient
WO2009078447A1 (ja) 抗ノロウイルス剤、抗インフルエンザウイルス剤、およびこれらを用いた抗ウイルス処理方法
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
WO2008003050A3 (en) Gallium nitrate formulations
EP1608395A4 (de) Antikrebsmittel mit lk8-protein als wirkstoff
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
EP1741430A4 (de) Mittel zur behandlung von psychoneurotischen krankheiten
WO2005065713A3 (de) Arzneimittel zur topischen applikation bei tieren
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2005707637

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11509613

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2005707637

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11509613

Country of ref document: US